Informationen:
Fehler:
ID
37404
Beschreibung
Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of Sulfonylurea; ODM derived from: https://clinicaltrials.gov/show/NCT02485132
Link
https://clinicaltrials.gov/show/NCT02485132
Stichworte
Versionen (1)
- 23.07.19 23.07.19 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
23. Juli 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Type 2 Diabetes NCT02485132
Eligibility Type 2 Diabetes NCT02485132
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Type 2 Diabetes NCT02485132
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes according to canadian diabetes association definition
boolean
C0011860 (UMLS CUI [1])
Gliclazide | Gliclazide MR
Item
initiation of gliclazide or gliclazide mr at baseline
boolean
C0017631 (UMLS CUI [1])
C0017631 (UMLS CUI [2,1])
C1709058 (UMLS CUI [2,2])
C0017631 (UMLS CUI [2,1])
C1709058 (UMLS CUI [2,2])
Metformin Stable
Item
currently treated with stable metformin monotherapy (≥3 months)
boolean
C0025598 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,2])
Hemoglobin A1c measurement
Item
a1c: 7.0% to 10.0%
boolean
C0474680 (UMLS CUI [1])
Protocol Compliance
Item
willing and able to comply with study procedures
boolean
C0525058 (UMLS CUI [1])
Hypoglycemic Agents | Exception Metformin
Item
current or previous usage of any other type of antihyperglycemic medication except metformin
boolean
C0020616 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0025598 (UMLS CUI [2,2])
C1705847 (UMLS CUI [2,1])
C0025598 (UMLS CUI [2,2])
Pharmaceutical Preparation Interferes with Glucose metabolism
Item
use of medication known to interfere with glucose metabolism
boolean
C0013227 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0596620 (UMLS CUI [1,3])
C0521102 (UMLS CUI [1,2])
C0596620 (UMLS CUI [1,3])
Patient need for Insulin | Catabolic state | Ketonuria
Item
insulin requiring patient: catabolic state and/or ketonuria
boolean
C0686904 (UMLS CUI [1,1])
C0021641 (UMLS CUI [1,2])
C0853892 (UMLS CUI [2])
C0162275 (UMLS CUI [3])
C0021641 (UMLS CUI [1,2])
C0853892 (UMLS CUI [2])
C0162275 (UMLS CUI [3])
Continuous glucose monitoring system
Item
currently using cgms or within the last 3 months
boolean
C4523945 (UMLS CUI [1,1])
C3888058 (UMLS CUI [1,2])
C3888058 (UMLS CUI [1,2])
Hypoglycemia Severe
Item
recent severe hypoglycemia (<3 months)
boolean
C0020615 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnancy or breast-feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Life Expectancy Limited | High Level Functional dependency | Coronary disease Extensive | At risk for acute ischemic cardiac event | High risk of Comorbidities major multiple
Item
limited life expectancy, high level of functional dependency, extensive coronary disease at high risk of short term ischemic events or multiple major co-morbidities
boolean
C0023671 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C4321237 (UMLS CUI [2,1])
C1268609 (UMLS CUI [2,2])
C0010068 (UMLS CUI [3,1])
C0205231 (UMLS CUI [3,2])
C1443393 (UMLS CUI [4])
C0332167 (UMLS CUI [5,1])
C0009488 (UMLS CUI [5,2])
C0205164 (UMLS CUI [5,3])
C0439064 (UMLS CUI [5,4])
C0439801 (UMLS CUI [1,2])
C4321237 (UMLS CUI [2,1])
C1268609 (UMLS CUI [2,2])
C0010068 (UMLS CUI [3,1])
C0205231 (UMLS CUI [3,2])
C1443393 (UMLS CUI [4])
C0332167 (UMLS CUI [5,1])
C0009488 (UMLS CUI [5,2])
C0205164 (UMLS CUI [5,3])
C0439064 (UMLS CUI [5,4])